Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Glooko, Inc.
During a panel at the 2022 BioFuture conference, panelists talked about how digital technology can provide data about drugs and devices on the market or in clinical trials.
In this month’s Digital Health roundup, Medtech Insight’s Barnaby Pickering discusses DeHealth, which developed a platform built on cryptocurrency, and executive interviews with Glooko and Omada Health about their diabetes platforms. Marion Webb will highlight a conversation with Nixon Gwilt Law attorney Bethany Corbin about key steps developers of period-tracking apps can take to ensure that sensitive health data remains safe and private. Reed Miller discusses Braidio’s health information platform and Pyx Health’s hybrid solution for loneliness.
Are digital solutions the missing link for diabetes care? Glooko and Omada Health think so. Both have developed device-integrating platforms to help patients manage their condition.
metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia explained their plans for the FDA-authorized, gut-directed hypnotherapy Regulora, including an openness to outcomes-based pricing and the wider go-to-market strategy.
- Monitoring Equipment & Devices
- Disease Management
- Artificial Intelligence
- Other Names / Subsidiaries
- Diasend AB